Cargando…
Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546534/ https://www.ncbi.nlm.nih.gov/pubmed/36247068 http://dx.doi.org/10.1016/j.medcle.2022.04.017 |
| _version_ | 1784805061562466304 |
|---|---|
| author | Aomar-Millán, Ismael F. Salvatierra, Juan Raya Álvarez, Enrique |
| author_facet | Aomar-Millán, Ismael F. Salvatierra, Juan Raya Álvarez, Enrique |
| author_sort | Aomar-Millán, Ismael F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9546534 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95465342022-10-11 Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia Aomar-Millán, Ismael F. Salvatierra, Juan Raya Álvarez, Enrique Med Clin (Engl Ed) Letter to the Editor Elsevier España, S.L.U. 2022-10-21 2022-09-30 /pmc/articles/PMC9546534/ /pubmed/36247068 http://dx.doi.org/10.1016/j.medcle.2022.04.017 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Aomar-Millán, Ismael F. Salvatierra, Juan Raya Álvarez, Enrique Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia |
| title | Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia |
| title_full | Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia |
| title_fullStr | Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia |
| title_full_unstemmed | Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia |
| title_short | Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia |
| title_sort | effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe covid-19 pneumonia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546534/ https://www.ncbi.nlm.nih.gov/pubmed/36247068 http://dx.doi.org/10.1016/j.medcle.2022.04.017 |
| work_keys_str_mv | AT aomarmillanismaelf effectoftocilizumabversusstandardofcareinadultshospitalizedwithmoderateseverecovid19pneumonia AT salvatierrajuan effectoftocilizumabversusstandardofcareinadultshospitalizedwithmoderateseverecovid19pneumonia AT rayaalvarezenrique effectoftocilizumabversusstandardofcareinadultshospitalizedwithmoderateseverecovid19pneumonia |